Telbivudine vs tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap study

AIM: To make efficacy and safety comparison of telbivudine-raodmap and tenofovir-roadmap in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients. METHODS: This was the first prospective, randomised, two-arm, open-label, non-inferiority study in HBeAg-negative CHB patients that c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Hepatol
Autors principals: Krastev, Zahari, Petrova, Diana, Kotzev, Iskren, Celen, Mustafa Kemal, Mendelson, Meryl, Chandra, Richa, Pandey, Priti, Hamed, Kamal
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2016
Matèries:
Randomized Clinical Trial
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5114476/
https://ncbi.nlm.nih.gov/pubmed/27917266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v8.i32.1402
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars